Clin2
NCT07417813Possibly a fitRecruiting

Lemborexant for insomnia in people with mental health conditions

InsomniaPsychiatric Disorders

Treatments studied

Part of Brain & nervous system, Mental health clinical trials.

This study tests if lemborexant, a sleep medication, can help people with both a mental health condition and insomnia. You would take the medicine as prescribed and complete questionnaires over 2 months.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
121 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You are 18 or older
  • You have been diagnosed with a mental health condition (like depression, anxiety, or bipolar disorder)
  • You have trouble sleeping, with a score of at least 11 on the Insomnia Severity Index
  • You have at least 7 hours available for sleep each night
  • You are able to attend follow-up visits for 2 months
  • Your doctor recommends trying a sleep medication called lemborexant

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06981195Recruiting· Phase 2
Testing lemborexant for insomnia in people on buprenorphine

This study tests if the sleep medication lemborexant can help people with opioid use disorder who also have chronic insomnia. Participants must already be taking buprenorphine (Suboxone) for at least 4 weeks. The goal is to see if better sleep improves mood and reduces opioid use.

Richmond, Virginia
NCT06823752Recruiting· Phase 2
Insomnia medication to reduce brain damage markers in adults

This trial tests whether a medication that blocks brain chemicals involved in wakefulness can help reduce markers of nerve damage in people with insomnia. It is for adults aged 40–65 with chronic insomnia, and it aims to see if improving sleep may protect brain health.

Macquarie Park, New South Wales
NCT06093126Recruiting· Phase 4
Lemborexant for insomnia in dementia: a personalized trial

This trial tests if the sleep medication lemborexant can help people with early-stage dementia who also have insomnia. It uses an N-of-1 design, meaning it will look at how you personally respond to the drug compared to a placebo.

Halifax, Nova Scotia
NCT07384429Not yet recruiting· Phase 4
Sleep medication for insomnia in Parkinson's disease

This trial tests a sleep medication called lemborexant in people with Parkinson's disease who also have insomnia. The goal is to see if it improves both sleep and movement symptoms.

Wuhan, Hubei
NCT06262594Recruiting· Phase 3
Testing a sleep medicine for epilepsy-related insomnia

This study tests a new sleep medicine called lemborexant for people with epilepsy whose seizures happen during sleep and who also have trouble sleeping. The goal is to see if the medicine can help you sleep better without making your seizures worse.

Durham, North Carolina
NCT06648681Not yet recruiting· Phase 2
Lemborexant to prevent confusion after heart surgery

This study tests whether a medication called lemborexant can help prevent confusion or delirium after open heart surgery. It might help you recover more clearly.

Vancouver, British Columbia

Hear when a new Insomnia trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.